<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Syndromol</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Syndromol</journal-id>
<journal-id journal-id-type="publisher-id">MSY</journal-id>
<journal-title-group>
<journal-title>Molecular Syndromology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1661-8769</issn>
<issn pub-type="epub">1661-8777</issn>
<publisher>
<publisher-name>S. Karger AG</publisher-name>
<publisher-loc>Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH–4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28588433</article-id>
<article-id pub-id-type="pmc">5448439</article-id>
<article-id pub-id-type="doi">10.1159/000456021</article-id>
<article-id pub-id-type="publisher-id">msy-0008-0118</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Intragenic <italic>CNTNAP2</italic> Deletions: A Bridge Too Far?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Poot</surname>
<given-names>Martin</given-names>
</name>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
</contrib-group>
<aff>Department of Human Genetics, University of Würzburg, Würzburg, Germany</aff>
<author-notes>
<corresp id="cor1">*Martin Poot, Department of Human Genetics, University of Würzburg, Biozentrum, Am Hubland, DE-97074 Würzburg, E-Mail <email>Martin_Poot@hotmail.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>11</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>8</volume>
<issue>3</issue>
<fpage>118</fpage>
<lpage>130</lpage>
<history>
<date date-type="accepted">
<day>6</day>
<month>12</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 by S. Karger AG, Basel</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<abstract>
<p>Intragenic deletions of the contactin-associated protein-like 2 gene (<italic>CNTNAP2</italic>) have been found in patients with Gilles de la Tourette syndrome, intellectual disability (ID), obsessive compulsive disorder, cortical dysplasia-focal epilepsy syndrome, autism, schizophrenia, Pitt-Hopkins syndrome, stuttering, and attention deficit hyperactivity disorder. A variety of molecular mechanisms, such as loss of transcription factor binding sites and perturbation of penetrance and expressivity, have been proposed to account for the phenotypic variability resulting from <italic>CNTNAP2</italic> mutations. Deletions of both <italic>CNTNAP2</italic> alleles produced truncated proteins lacking the transmembrane or some of the extracellular domains, or no protein at all. This observation can be extended to heterozygous intragenic deletions by assuming that such deletion-containing alleles lead to expression of a Caspr2 protein lacking one or several extracellular domains. Such altered forms of Capr2 proteins will lack the ability to bridge the intercellular space between neurons by binding to partners, such as CNTN1, CNTN2, DLG1, and DLG4. This presumed effect of intragenic deletions of <italic>CNTNAP2</italic>, and possibly other genes involved in connecting neuronal cells, represents a molecular basis for the postulated neuronal hypoconnectivity in autism and probably other neurodevelopmental disorders, including epilepsy, ID, language impairments and schizophrenia. Thus, <italic>CNTNAP2</italic> may represent a paradigmatic case of a gene functioning as a node in a genetic and cellular network governing brain development and acquisition of higher cognitive functions.</p>
</abstract>
<kwd-group>
<title>Keywords</title>
<kwd>
<italic>CNTNAP2</italic>
</kwd>
<kwd>Intragenic deletions</kwd>
<kwd>Neurodevelopmental disorders</kwd>
</kwd-group>
<counts>
<fig-count count="5"></fig-count>
<ref-count count="88"></ref-count>
<page-count count="13"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>